# INSPRA
> **NDA021437** · New Drug Application · Sponsor: UPJOHN · Approved 2002-09-27
## Drug
- **FDA Application Number:** NDA021437
- **Application type:** New Drug Application
- **Brand name:** INSPRA
- **Generic name:** EPLERENONE
- **Active ingredients:** EPLERENONE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** UPJOHN
- **Manufacturer:** Mylan Pharmaceuticals Inc.
- **First approval:** 2002-09-27
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021437)
---
*AI Analytics · CC0 1.0*